Omicron Clouds Novavax’s Delayed COVID-19 Vaccine Debut
After Repeated Delays, Investors Doubt Readiness
Novavax has already gained its first emergency use authorization for its COVID-19 vaccine, but doubts remain about its manufacturing and Omicron readiness.
